Valuation: Thor Medical

Market Cap 169.63Cr 18Cr 17Cr 15Cr 14Cr 26Cr 1.75TCr 26Cr 181.17Cr 73Cr 921.11Cr 69Cr 68Cr 2.9TCr P/E 2026 *
-18.7x
P/E 2027 * -73x
Enterprise Value 169.13Cr 18Cr 16Cr 15Cr 14Cr 26Cr 1.75TCr 26Cr 180.64Cr 73Cr 918.4Cr 69Cr 68Cr 2.9TCr EV / Sales 2026 *
89x
EV / Sales 2027 * 11.5x
Free-Float
75.21%
Yield 2026 *
-
Yield 2027 * -
1 day-4.74%
1 week-4.40%
1 month-10.18%
3 months-30.66%
6 months-9.27%
Current year-23.52%
1 week 3.98
Extreme 3.98
4.39
1 month 3.98
Extreme 3.98
4.6
Current year 3.88
Extreme 3.88
7.12
1 year 3.41
Extreme 3.41
7.12
3 years 0.85
Extreme 0.85
7.12
5 years 0.85
Extreme 0.85
7.12
10 years 0.85
Extreme 0.85
7.12
Manager TitleAgeSince
Chief Executive Officer 41 01/08/2024
Director of Finance/CFO 37 01/07/2023
Chief Tech/Sci/R&D Officer - 01/06/2023
Director TitleAgeSince
Director/Board Member 67 28/06/2023
Chairman 59 -
Director/Board Member - 24/04/2025
Date Insider Type Main position Quantity % Market Cap. Importance
26/06/25
Scatec Innovation AS
OthersCompany 3,15,77,399 10.0434%
18/06/25
Scatec Innovation AS
BuyCompany 30,00,000 0.9542%
02/05/25 Exercice

Director

1,64,641 0.0524%
Change 5-day change 1-year change 3-year change Capi.($)
-4.74%-4.40%+12.46%+216.14% 18Cr
-0.62%-1.87%+42.87%+64.15% 6.38TCr
+0.35%+3.20%+14.40%+81.76% 5.64TCr
+0.53%+1.96%+16.24%+103.35% 5.46TCr
-2.81%-4.31%+23.50%+47.83% 4.41TCr
-0.33%-1.93%+19.28%+98.80% 4.21TCr
+0.55%+2.31%+225.14%+866.21% 4.1TCr
+3.27%+47.96%+112.84%+96.58% 3.49TCr
+1.22%-1.44%+14.57%+46.95% 3.28TCr
+0.89%+20.55%-40.62%+349.24% 2.47TCr
Average -0.17%+6.34%+44.07%+197.10% 3.95TCr
Weighted average by Cap. +0.18%+5.44%+47.98%+176.69%

Financials

2026 *2027 *
Net sales 1.9Cr 20.66L 18.5L 17.02L 15.42L 28.82L 20Cr 29.36L 2.03Cr 81.46L 10Cr 77.52L 75.87L 33Cr 14Cr 1.56Cr 1.39Cr 1.28Cr 1.16Cr 2.17Cr 147.87Cr 2.21Cr 15Cr 6.14Cr 78Cr 5.84Cr 5.72Cr 245.3Cr
Net income -8.05Cr -87.52L -78.38L -72.1L -65.33L -1.22Cr -83Cr -1.24Cr -8.6Cr -3.45Cr -44Cr -3.28Cr -3.21Cr -137.85Cr -2.35Cr -25.55L -22.88L -21.05L -19.07L -35.65L -24Cr -36.31L -2.51Cr -1.01Cr -13Cr -95.88L -93.84L -40Cr
Net Debt -50L -5L -5L -4L -4L -8L -5.16Cr -8L -53.4L -21.44L -2.71Cr -20.4L -19.97L -8.56Cr -4.35Cr -47.29L -42.35L -38.96L -35.3L -65.98L -45Cr -67.22L -4.65Cr -1.87Cr -24Cr -1.77Cr -1.74Cr -74Cr
Projected Income Statement - Annual - Thor Medical
Logo Thor Medical
Thor Medical ASA, formerly Nordic Nanovector ASA, is a Norway-based biopharmaceutical company. The Company is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium. The Company is utilizing alpha-emitters in radiotherapy and cancer treatments using Pb-212, which can be produced from naturally occurring isotope Thorium-232 and Lead-212. The Company has developed a proprietary technology for the manufacturing of radionuclides, primarily alpha-particle emitters from natural resources. The high energy deposition and the short range of alpha particles make it possible to eradicate cancer cells while minimizing damage to nearby healthy cells
Employees
24
Date Price Change Volume
30/26/30 NOK 4.015 -4.74% 49,56,256
29/26/29 NOK 4.215 +1.32% 24,79,108
28/26/28 NOK 4.160 -1.77% 14,31,987
27/26/27 NOK 4.235 +1.93% 32,64,078
26/26/26 NOK 4.155 -1.07% 26,26,007
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
4.015NOK
Average target price
5.600NOK
Spread / Average Target
+39.48%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Thor Medical
  1. Stock Market
  2. Stocks
  3. NANOV Stock